LIFEPOINT INC 4

4 · LIFEPOINT INC · Filed Nov 17, 1999

Insider Transaction Report

Form 4

Period: 1999-10-31

LIFEPOINT INC

Masterson Linda H.

Chairman of the Board, President and Chief Executive Officer

Transactions

Award
Stock Option
1999-10-10+120,000
Exercise: $1.68Exp: 2009-10-09→ Common Stock (120,000 underlying)
Award
Common Stock Purchase
1999-10-10+1
Exercise: $1.72→ Common Stock (1 underlying)
Award
Common Stock Purchase
1999-10-10+1
Exercise: $1.72→ Common Stock (1 underlying)
Award
Common Stock Purchase
1999-10-10+1
Exercise: $1.72→ Common Stock (1 underlying)
Award
Common Stock Purchase
1999-10-10+1
Exercise: $1.72→ Common Stock (1 underlying)
Award
Common Stock Purchase
1999-10-10+1
Exercise: $1.72→ Common Stock (1 underlying)

Footnotes (11)

[1]Option becomes exercisable as to 30,000 shares on 10/10/00, and as to 2,500 shares on the 10th of each month for 36 months thereafter.
[10]Warrant becomes exercisable only if the Issuer derives revenues of $100,000 from sales of its saliva based testing product prior to January 1, 2001 and the reporting person is CEO of Issuer on the date sales are consummated.
[11]The earlier of the day before the 5th Anniversary of the day on which sales for $100,000 of Issuer's product are consummated or December 31, 2005. /s/ Linda H. Masterson 11/5/99 ---------------------------------------------
[2]Warrant becomes exercisable only if the Issuer enters into a strategic partnership arrangement prior to October 10, 2001 and the reporting person is still CEO of the Issuer at such time.
[3]The earlier of the 5th anniversary of the day before the day on which a strategic partnership agreement is executed, or October 9, 2006.
[4]Warrant becomes exercisable only if the warrant in note #2 becomes exercisable and the Issuer executed, prior to October 10, 2001, a definitive agreement with a second strategic partner and the reporting person is still CEO of Issuer at such time.
[5]The earlier of the 5th anniversary of the day before the day on which the second strategic partnership is executed or October 9, 2006.
[6]Warrant becomes exercisable only if Issuer secures financing of at least $4,500,000 prior to October 10, 2000 and the reporting person is still CEO at such time.
[7]The earlier of the day before the 5th anniversary of the closing date of the financing (see note #6) or October 9, 2005.
[8]Warrant becomes exercisable only if the Issuer completes certain clinical trails before October 1, 2000 and the reporting person is CEO of Issuer on the date such trials are completed.
[9]The earlier of the day before the 5th anniversary of the day on which certain clinical trails are completed or September 30, 2005.

Documents

1 file

4
Primary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP